Yonggong Yang
321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Clinical Research on Microecological Landscape for Infection Risk Stratification in Newly Diagnosed Patients with Hematological Conditions.
Journal: Infectious diseases and therapy
Published: April 16, 2026
Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database.
Journal: Frontiers in pharmacology
Published: August 26, 2024
Olverembatinib treatment in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal: Annals of hematology
Published: June 11, 2024
Correction to: Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia.
Journal: Annals of hematology
Published: March 27, 2024
Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia.
Journal: Annals of hematology
Published: October 11, 2023
A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS).
Journal: Therapeutic advances in drug safety
Published: August 10, 2023
Reduced-dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B-cell acute lymphoblastic leukemia.
Journal: Cancer medicine
Published: June 12, 2023
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies.
Journal: International journal of antimicrobial agents
Published: November 10, 2022
Hepatitis B virus infection and 1q21 amplification in multiple myeloma.
Journal: Oncology letters
Published: September 14, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026